Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations

NCT03404817 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Cocaine Use Disorder

Interventions

DRUG: Original formulation EMB-001
DRUG: New formulation EMB-001

Sponsor

Embera NeuroTherapeutics, Inc.

Collaborators

[object Object]